Transarterial Chemoembolization, TACE, is a Treatment Option for Liver Cancer

At The Center for Liver and Hepatobiliary Diseases at Mercy, Dr. Paul Thuluvath, Dr. Anurag Maheshwari and Dr. Hwan Yoo offer some of the best treatment options available for liver diseases. Specializing in liver cancer diagnosis and treatment, Mercy's doctors offer transarterial chemoembolization as a treatment for liver cancer.

What is Transarterial Chemoembolization or TACE?

Transarterial chemoembolization is a minimally invasive procedure that allows for chemotherapy to be administered directly into a liver tumor while blocking the tumor’s blood supply. 

How is a Transarterial Chemoembolization performed?

During a transarterial chemoembolization, a catheter is inserted into an incision in the groin area. The catheter is guided through blood vessels to the liver. Through the catheter, the chemotherapy is targeted directly to the liver tumor. The embolization materials also are inserted through the catheter and are used to block the blood supply. This blocking of the blood supply during transarterial chemoembolization enables the chemotherapy to stay in the liver rather than be carried through the blood stream. 

When is Transarterial Chemoembolization a treatment option?

Transarterial chemoembolization is a treatment option for liver cancer.

The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy provides diagnosis and treatment for a range of gastroenterology issues including heartburn, liver disease, bowel conditions, motility disorders and pancreatic disease.